Published date: 22 July 2021

This notice was replaced on 22 July 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 22 July 2021, last edited 6 August 2021)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.



Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

England

Value of contract

£3,185,000,000

Procurement reference

CF-0272200D0O000000rwimUAA1

Published date

22 July 2021

Closing date

3 September 2021

Closing time

1pm

Contract start date

1 November 2021

Contract end date

31 March 2024

Contract type

Supply contract

Procedure type

Open procedure (OJEU)

Any interested supplier may submit a tender in response to an opportunity notice.

OJEU (Official Journal of the European Union) procedures are valued above a certain financial threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No


Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).

Period of Framework: 01/11/2021 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 41 months)

All documents can be found at https://health.atamis.co.uk/. Atamis Reference Number: C40079


About the buyer

Contact name

Gero Lo Manto

Address

80 London Road
London
SE1 6LH
GB

Email

gero.lomanto@nhs.net